Prosecution Insights
Last updated: August 15, 2026

Wake Forest University Health Sciences

13 pending office actions • 10 art units • 12 examiners • 0 of 13 (0%) have an AI response strategy ready • 17 patents granted in the last 365 days

Portfolio Summary

13
Total Pending OAs
10
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
2
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (1)Due ≤ 30 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

9
Hard (69%)
4
Medium (31%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other5 (38%)
§103 only3 (23%)
Double-patenting + other1 (8%)
Multi-statute (no §101)4 (31%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

10
Life Sciences
77% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
8% of docket
0
Mechanical / Eng
0% of docket
2
Business / Other
15% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

130 h
Manual time on pending OAs
26 h
Time saved (low, 20%)
46 h
Time saved (mid, 35%)
1.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MOLOYE, TITILAYO 2 63.1% +47.1%
COFFA, SERGIO 1 61.1% +33.2%
WESTON, ALYSSA G 1 60.0% +51.3%
DONOHUE, SEAN R 1 41.4% +21.1%
NICOL, ALEXANDER W 1 42.9% +43.1%
POLIAKOVA-GEORGAN, EKATERINA 1 64.0% +17.9%
XIAO, YAN 1 67.8% +51.6%
DO, AN H 1 90.6% +6.9%
HENKEL, DANIELLE B 1 56.3% +24.0%
KIM, TAEYOON 1 51.6% +51.8%

Hard Cases (9)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18603721 COMPOUNDS AND COMPOSITIONS USEFUL AS RADIOTRACERS FOR IMAGING OF REACTIVE OXIDATIVE SPECIES DONOHUE, SEAN R 28d overdue
18731629 ORGANOIDS RELATED TO IMMUNOTHERAPY AND METHODS OF PREPARING AND USING THE SAME WESTON, ALYSSA G
18544936 COMPOSITIONS, CELL CONSTRUCTS, AND METHODS OF MAKING AND USING THE SAME MOLOYE, TITILAYO
18037708 VECTORS, SYSTEMS AND METHODS FOR EUKARYOTIC GENE EDITING POLIAKOVA-GEORGAN, EKATERINA
18157759 CALIBRATION OF SOLID-STATE SENSORS DO, AN H
17779241 Microwell Perfusion Plates for Organoids and Related Systems and Methods HENKEL, DANIELLE B
17644244 METHODS OF TREATMENT FOR KIDNEY DISEASE KIM, TAEYOON
17643441 BLOOD BRAIN BARRIER MODEL AND METHODS OF MAKING AND USING THE SAME MOLOYE, TITILAYO

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18603721 COMPOUNDS AND COMPOSITIONS USEFUL AS RADIOTRACERS FOR IMAGING OF REACTIVE OXIDATIVE SPECIES DONOHUE, SEAN R 28d overdue
18276812 ENGINEERED EXTRACELLULAR VESICLES AND THEIR USES NICOL, ALEXANDER W 9d
18316672 EPHA3 AND MULTI-VALENT TARGETING OF TUMORS XIAO, YAN 21d
18794181 AMNIOTIC MEMBRANE POWDER AND ITS USE IN WOUND HEALING AND TISSUE ENGINEERING CONSTRUCTS COFFA, SERGIO
18731629 ORGANOIDS RELATED TO IMMUNOTHERAPY AND METHODS OF PREPARING AND USING THE SAME WESTON, ALYSSA G
18544936 COMPOSITIONS, CELL CONSTRUCTS, AND METHODS OF MAKING AND USING THE SAME MOLOYE, TITILAYO
18037708 VECTORS, SYSTEMS AND METHODS FOR EUKARYOTIC GENE EDITING POLIAKOVA-GEORGAN, EKATERINA
17779241 Microwell Perfusion Plates for Organoids and Related Systems and Methods HENKEL, DANIELLE B

Top Art Units

Art UnitApps
1632 2
1658 1
1618 1
1634 1
1637 1
1642 1
2853 1
1799 1
1631 1
1682 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18794181 AMNIOTIC MEMBRANE POWDER AND ITS USE IN WOUND HEALING AND TISSUE ENGINEERING CONSTRUCTS COFFA, SERGIO 1658 §103DP Non-Final OA Pending Aug 05, 2024
18731629 ORGANOIDS RELATED TO IMMUNOTHERAPY AND METHODS OF PREPARING AND USING THE SAME WESTON, ALYSSA G §101§102§103§112DP Non-Final OA Pending Jun 03, 2024
18603721 COMPOUNDS AND COMPOSITIONS USEFUL AS RADIOTRACERS FOR IMAGING OF REACTIVE OXIDATIVE SPECIES DONOHUE, SEAN R 1618 §103§112 Final Rejection 28d overdue Pending Mar 13, 2024
18544936 COMPOSITIONS, CELL CONSTRUCTS, AND METHODS OF MAKING AND USING THE SAME MOLOYE, TITILAYO §103§112 Non-Final OA Pending Dec 19, 2023
18276812 ENGINEERED EXTRACELLULAR VESICLES AND THEIR USES NICOL, ALEXANDER W 1634 §103 Non-Final OA 9d Pending Aug 10, 2023
18037708 VECTORS, SYSTEMS AND METHODS FOR EUKARYOTIC GENE EDITING POLIAKOVA-GEORGAN, EKATERINA 1637 §101§103DP Non-Final OA Pending May 18, 2023
18316672 EPHA3 AND MULTI-VALENT TARGETING OF TUMORS XIAO, YAN 1642 §103 Final Rejection 21d Pending May 12, 2023
18157759 CALIBRATION OF SOLID-STATE SENSORS DO, AN H 2853 §101§102 Non-Final OA Pending Jan 20, 2023
17779241 Microwell Perfusion Plates for Organoids and Related Systems and Methods HENKEL, DANIELLE B 1799 §102§103§112 Non-Final OA Pending May 24, 2022
17644244 METHODS OF TREATMENT FOR KIDNEY DISEASE KIM, TAEYOON 1631 §103§112 Non-Final OA Pending Dec 14, 2021
17643441 BLOOD BRAIN BARRIER MODEL AND METHODS OF MAKING AND USING THE SAME MOLOYE, TITILAYO 1632 §101§103 Non-Final OA Pending Dec 09, 2021
17607995 MINIMAL PROCESSING METHOD FOR DECELLULARIZATION OF TISSUES MONTANARI, DAVID A 1632 §103 Final Rejection Pending Nov 01, 2021
16921287 METHODS OF PREDICTING PREDISPOSITION TO OR RISK OF KIDNEY DISEASE SITTON, JEHANNE SOUAYA 1682 §101§112DP Non-Final OA Pending Jul 06, 2020

Managing Wake Forest University Health Sciences's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month